Melanoma Development Linked to Relationship Between Pigment Synthesis and Mitochondrial Function
By LabMedica International staff writers Posted on 11 Jan 2015 |
Image: Melanin pigment (light refracting granular material - center of image) in a pigmented melanoma (Photo courtesy of Wikimedia Commons).
Development of melanoma, a potentially fatal type of skin cancer, is linked to the direct relationship between pigment production (melanogenesis) and generation of reactive oxygen species (ROS) by the mitochondria.
Melanogenesis is a highly conserved process in many species that protects cells from UV radiation damage. Although both mitochondrial function and UV radiation damage are well-documented promoters of increased cellular stress, their individual molecular relationships with skin pigmentation have not been clearly resolved.
Investigators at the University of Newcastle (United Kingdom) presented evidence for a direct relationship between cellular melanin content, superoxide flux, and mitochondrial function at Complex II. They examined three types of melanoma skin cancer cell lines that displayed low, medium, or high pigment levels and analyzed their ROS levels and mitochondrial Complex II function.
Results showed that the darker the cells, the higher ROS generation and Complex II function. When cells with lower melanin levels were induced to produce more by augmenting them with L-tyrosine, a building block for melanin production, these cell types gradually exhibited higher pigment levels, while simultaneously showing increased Complex II function.
"This study reports a novel correlation between proteins involved in the bioenergy process within the human skin (i.e., Complex II) and skin pigmentation," said Dr. Mark Birch-Machin, professor of molecular dermatology at Newcastle University. "This leads to interesting possibilities of Complex II playing a central role in coupling stress sensing and cellular adaptation via ROS signaling, and as this study was performed in skin cancer cells, may help in the development of anticancer drugs."
The study was published in the January 2015 issue of the FASEB Journal.
Related Links:
University of Newcastle
Melanogenesis is a highly conserved process in many species that protects cells from UV radiation damage. Although both mitochondrial function and UV radiation damage are well-documented promoters of increased cellular stress, their individual molecular relationships with skin pigmentation have not been clearly resolved.
Investigators at the University of Newcastle (United Kingdom) presented evidence for a direct relationship between cellular melanin content, superoxide flux, and mitochondrial function at Complex II. They examined three types of melanoma skin cancer cell lines that displayed low, medium, or high pigment levels and analyzed their ROS levels and mitochondrial Complex II function.
Results showed that the darker the cells, the higher ROS generation and Complex II function. When cells with lower melanin levels were induced to produce more by augmenting them with L-tyrosine, a building block for melanin production, these cell types gradually exhibited higher pigment levels, while simultaneously showing increased Complex II function.
"This study reports a novel correlation between proteins involved in the bioenergy process within the human skin (i.e., Complex II) and skin pigmentation," said Dr. Mark Birch-Machin, professor of molecular dermatology at Newcastle University. "This leads to interesting possibilities of Complex II playing a central role in coupling stress sensing and cellular adaptation via ROS signaling, and as this study was performed in skin cancer cells, may help in the development of anticancer drugs."
The study was published in the January 2015 issue of the FASEB Journal.
Related Links:
University of Newcastle
Latest Pathology News
- AI Integrated With Optical Imaging Technology Enables Rapid Intraoperative Diagnosis
- HPV Self-Collection Solution Improves Access to Cervical Cancer Testing
- Hyperspectral Dark-Field Microscopy Enables Rapid and Accurate Identification of Cancerous Tissues
- AI Advancements Enable Leap into 3D Pathology
- New Blood Test Device Modeled on Leeches to Help Diagnose Malaria
- Robotic Blood Drawing Device to Revolutionize Sample Collection for Diagnostic Testing
- Use of DICOM Images for Pathology Diagnostics Marks Significant Step towards Standardization
- First of Its Kind Universal Tool to Revolutionize Sample Collection for Diagnostic Tests
- AI-Powered Digital Imaging System to Revolutionize Cancer Diagnosis
- New Mycobacterium Tuberculosis Panel to Support Real-Time Surveillance and Combat Antimicrobial Resistance
- New Method Offers Sustainable Approach to Universal Metabolic Cancer Diagnosis
- Spatial Tissue Analysis Identifies Patterns Associated With Ovarian Cancer Relapse
- Unique Hand-Warming Technology Supports High-Quality Fingertip Blood Sample Collection
- Image-Based AI Shows Promise for Parasite Detection in Digitized Stool Samples
- Deep Learning Powered AI Algorithms Improve Skin Cancer Diagnostic Accuracy
- Microfluidic Device for Cancer Detection Precisely Separates Tumor Entities